We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Oxygen Levels Predict Stroke Risk in Children with Sickle Cell Anemia

By Labmedica staff writers
Posted on 10 Mar 2008
People with sickle cell disease have a genetic error affecting their hemoglobin. More...
The defect turns normally soft, round erythrocytes into inflexible, sickle-shaped cells. The altered shape causes blockages in blood vessels and prevents body tissues from receiving oxygen. Scientists have determined that the level, or saturation, of oxygen in blood could be used to identify children with sickle cell anemia who are at an increased risk of stroke.

Investigators reviewed the cases of 412 children with sickle cell disease who were initially diagnosed by newborn screening. All patients reviewed were born after January 1, 1990, a date chosen because patient data were available electronically. Oxygen saturation in the children's blood was tracked over time, and the records of those who suffered a stroke were compared to those who did not. The study found that children who had lower levels of oxygen in their blood were more likely to develop stroke.

The study was carried out by a team of investigators from the University of Texas (UT) Southwestern Medical Center (Dallas, TX, USA) and was reported the February 2008 edition of the British Journal of Haematology (BJH).
"A decline in oxygen saturation over time seems to further increase the risk of stroke,” said Dr. Quinn, assistant professor of pediatrics at UT Southwestern and lead author of the study. "Oxygen saturation is easily measured, potentially modifiable, and might be used to identify children with sickle cell disease who are at greater risk of having a stroke.”

Another study by Dr. Quinn and his colleagues appeared in the January 2008 issue of the journal Blood. That study examined how effectively a model developed by the Cooperative Study of Sickle Cell Disease (CSSCD) predicted severe disease in the newborn cohort. The CSSCD criteria, which evaluates patients based on factors such as occurrences of dactylitis--a type of painful swelling of the hands and feet--in the first year of life, steady-state hemoglobin concentration, and steady-state leukocyte count in the second year of life, was created in hopes that a predictive model would allow early, tailored therapy to prevent adverse outcomes.

Dr. Quinn reported that the findings suggest that the CSSCD model should not be used as the sole criterion to initiate early, high-risk intervention, and that a robust early prediction model is still needed.


Related Links:
University of Texas Southwestern Medical Center

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.